Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|June 23, 2016
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug AdministrationReona Sakemura, Seitaro Terakura, Keisuke Watanabe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2016
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell ImmunotherapyTatsunori Goto, Tetsuya Nishida, Erina Takagi, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2003
Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cellsMikinori Miyazaki, Yoshiki Akatsuka, Tetsuya Nishida, et al.
The Journal of Experimental Medicine|May 29, 2003
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensYoshiki Akatsuka, Tetsuya Nishida, Eisei Kondo, et al.
International Journal of Hematology|September 28, 2019
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantationSonoko Kamoshita, Makoto Murata, Daisuke Koyama, et al.
Cancer Immunology Research|April 15, 2018
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLsKotaro Miyao, Seitaro Terakura, Shingo Okuno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2021
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T CellsShingo Okuno, Yoshitaka Adachi, Seitaro Terakura, et al.
Blood|March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cellsMarie Bleakley, Brith E Otterud, Julia L Richardt, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 7, 2020
[Successful treatment of pre-engraftment disseminated fusariosis with high-dose liposomal amphotericin B in a cord blood transplant recipient]Yasuhiko Harada, Makoto Murata, Akane Matsumoto, et al.
International Journal of Hematology|June 22, 2006
High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantationTatsuya Adachi, Tadashi Matsushita, Ryoichi Ichihashi, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|June 23, 2016
A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug AdministrationReona Sakemura, Seitaro Terakura, Keisuke Watanabe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 23, 2016
Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell ImmunotherapyTatsunori Goto, Tetsuya Nishida, Erina Takagi, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2003
Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cellsMikinori Miyazaki, Yoshiki Akatsuka, Tetsuya Nishida, et al.
The Journal of Experimental Medicine|May 29, 2003
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensYoshiki Akatsuka, Tetsuya Nishida, Eisei Kondo, et al.
International Journal of Hematology|September 28, 2019
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantationSonoko Kamoshita, Makoto Murata, Daisuke Koyama, et al.
Cancer Immunology Research|April 15, 2018
Introduction of Genetically Modified CD3ζ Improves Proliferation and Persistence of Antigen-Specific CTLsKotaro Miyao, Seitaro Terakura, Shingo Okuno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2021
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T CellsShingo Okuno, Yoshitaka Adachi, Seitaro Terakura, et al.
Blood|March 6, 2010
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cellsMarie Bleakley, Brith E Otterud, Julia L Richardt, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 7, 2020
[Successful treatment of pre-engraftment disseminated fusariosis with high-dose liposomal amphotericin B in a cord blood transplant recipient]Yasuhiko Harada, Makoto Murata, Akane Matsumoto, et al.
International Journal of Hematology|June 22, 2006
High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantationTatsuya Adachi, Tadashi Matsushita, Ryoichi Ichihashi, et al.
Pageof 17